When to transfuse? study tests best blood strategy for heart patients after surgery
NCT ID NCT03229941
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 1,424 veterans at high risk for heart problems who had major surgery. It compared two approaches to blood transfusion: a liberal strategy (transfusing when hemoglobin drops below 10) versus a restrictive strategy (transfusing only when hemoglobin drops below 7). The goal was to see which approach better prevents complications like heart attack, kidney failure, stroke, or death within 90 days after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
1,424 people
The number who actually took part.
- Started
-
Feb 2018
- Finished
-
Mar 2024
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Males and females older than 18 years of age who have postoperative Hb \< 10gm/dl within 15 days after the index operation * Patients who undergo an operation in either one of the three following categories: * Veterans who undergo PAD - related operations including but not limited to the following: * aortobifemoral or aortobiiliac bypass * open abdominal aortic aneurysm repair with simultaneous repair of aortoiliac occlusive disease * visceral bypass * iliofemoral bypass * femoral bypass or endarterectomy * infrainguinal bypass * thromboembolectomy * supra-aortic trunk bypass or endarterectomy * carotid endarterectomy * major lower extremity amputations (transfemoral, through the knee, or transtibial) * Veterans with past medical history of ischemic stroke or IHD or PAD who undergo the following general surgery procedures, defined as: * known prior MI * ECG findings consistent with prior MI * prior percutaneous coronary intervention * prior coronary artery bypass surgery * history of angina for which the patient is currently receiving treatment * stress test indicating myocardial ischemia * who undergo the following General Surgery operations: * Open cholecystectomy or other complex biliary reconstruction * such as open common bile duct exploration for stones * reconstruction as part of oncologic operations such as palliative pancreatic cancer procedures) * small bowel resection * pancreatectomy * colon resection * rectal resection * splenectomy * transhiatal esophagectomy * liver resection * gastric resection * open ventral hernia repair * Colostomies (reversals and takedowns) * Intestinal anastomosis takedowns and revisions * Gastric bypass * Adrenalectomies * Major diaphragmatic hiatal hernia repairs * Veterans with past medical history of ischemic stroke or IHD or PAD who undergo the following Vascular Surgery operations: * Open aneurysm repair, including but not limited to: * carotid * subclavian * abdominal aortic * iliac * femoral * popliteal aneurysms * and complex endovascular aneurysm repair, defined as: * fenestrated endograft * or endograft with need for iliac conduit * or endovascular aneurysm repair with simultaneous femoral artery reconstruction or bypass * Subclavian/vertebral bypasses and transpositions * Patients undergoing the above procedures will be included in the study regardless of their preoperative Hb level, and regardless of preoperative or intraoperative transfusion they might have received. Exclusion Criteria: * Veteran unable to consent * Veteran unwilling to follow protocol (such as Jehovah's witnesses) * Veteran with known history of hereditary anemias such as Thalassemia or Sickle cell disease * Veteran with known history of hereditary bleeding disorders, such as factor VIII or factor IX deficiency * Veteran with prior history of adverse reaction to blood administration, such as fever, rash, or hemolysis * Veteran does not speak or understand English * Veteran hemodynamically unstable or in cardiogenic shock for \>48 hours after the index procedure * Veteran participating in another interventional trial whose objective is to evaluate the effect of transfusion on outcomes * Pregnancy in female Veterans * Veteran is a prisoner or in custody of law enforcement * Prior randomization in the CSP#599 * Patients who are known to have tested positive for COVID-19 and have not recovered prior to consent will not be consented. Any participant who is known to have a positive COVID-19 test during the screening process and has not recovered will be excluded prior to randomization.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute renal failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asheville VA Medical Center, Asheville, NC
Asheville, North Carolina, 28805, United States
-
Central Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR
Little Rock, Arkansas, 72205-5484, United States
-
James A. Haley Veterans' Hospital, Tampa, FL
Tampa, Florida, 33612, United States
-
Louis Stokes VA Medical Center, Cleveland, OH
Cleveland, Ohio, 44106, United States
-
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, 77030, United States
-
Minneapolis VA Health Care System, Minneapolis, MN
Minneapolis, Minnesota, 55417, United States
-
North Florida/South Georgia Veterans Health System, Gainesville, FL
Gainesville, Florida, 32608, United States
-
San Francisco VA Medical Center, San Francisco, CA
San Francisco, California, 94121, United States
-
VA Loma Linda Healthcare System, Loma Linda, CA
Loma Linda, California, 92357, United States
-
VA Long Beach Healthcare System, Long Beach, CA
Long Beach, California, 90822, United States
-
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
Dallas, Texas, 75216, United States
-
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, 94304-1290, United States
-
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
Pittsburgh, Pennsylvania, 15240, United States
-
VA Portland Health Care System, Portland, OR
Portland, Oregon, 97239, United States
-
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Seattle, Washington, 98108, United States
-
VA Western New York Healthcare System, Buffalo, NY
Buffalo, New York, 14215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a checklist and heart monitor stop repeat strokes?
- Heart hole or stroke trigger? global registry tracks who gets closure and what happens next
- Two ways to catch a hidden heart rhythm after stroke
- Smartwatch-Coached walking at home put to the test for leg artery disease
- Blood test may reveal who recovers after a stroke
- Can a smart bracelet and app stop a second stroke?